Metal Nanoparticles
|
Gold nanoparticles |
Salmonella typhimurium |
DNA aptamer |
36 CFU/mL |
[33] |
Gold nanoparticles |
Dipicolinic acid |
Eu3+ ion/gold nanocluster |
0.8 μM |
[34] |
Gold nanoparticles |
Histamine |
Gold nanoparticles |
2.04 nM |
[35] |
Silver nanoparticles |
Melamine |
Polyethyleneimine–silver nanobioprobe |
132 nM |
[36] |
Silver nanoparticles |
Staphylococcal enterotoxin A |
DNA aptamer |
0.3393 ng/mL |
[37] |
Silver nanoparticles |
Fe+3 ions |
Vitamin B12-functionalized biological silver nanoparticles (FAgNPs) |
2 mg/L |
[38] |
Copper nanoparticles |
Zearalenone |
Antibodies |
16.0 μg/kg |
[39] |
Platinum nanoparticles |
Hypoxanthine |
Platinum nanoparticles |
2.88 μM |
[40] |
Tungsten nanoparticles |
Maltose and sucrose |
Fenugreek β-amylase functionalized tungsten disulfide nanoparticles |
0.052 and 0.096 mM |
[41] |
Palladium nanoparticles |
Tetracyclines |
Graphene quantum dots/palladium nanoparticles |
45 ng/mL |
[42] |
Carbon-based nanomaterials
|
Carbon nanotubes |
Escherichia coli O157:H7 |
Carbonyl iron powder/MWCNT-DNA aptamer |
3.15 × 102 cfu/mL |
[43] |
Carbon nanotubes |
Patulin mycotoxin |
Carboxyfluorescein dye MWCNTs–DNA aptamer |
0.13 μg/L |
[44] |
Carbon nanohorns |
Fipronil |
FAM–aptamer with oxidized single-walled carbon nanohorns |
3 nM |
[45] |
Carbon dots |
Tartrazine |
Fluorescent carbon dots |
12.4 nM |
[46] |
Carbon dots |
Tetracyclines and Al3+
|
Fluorescent carbon dots |
0.057–0.23 μM and 0.091 μM |
[47] |
Carbon dots |
Ascorbic acid |
Carbon Dots/Fe3+ composite |
3.11 μmol·L-1 μmol/L |
[48] |
Quantum dots |
Acrylamide |
DNA aptamer |
2.41 × 10−8 M |
[49] |
Quantum dots |
Histamine |
Carbon quantum dots with peptide |
13 μg/kg |
[50] |
Quantum dots |
Biogenic amines |
Carbon dots/yellow fluorescent CdTe quantum dots |
1.259-5.428 μM |
[51] |
Graphene oxide |
β-lactoglobulin |
DNA aptamer |
96.91 μg/L |
[32] |
Graphene quantum dots |
Formaldehyde |
Graphene quantum dots |
0.0515 μg/mL |
[52] |
Graphene oxide |
Zearalenone and ochratoxin A |
Cy3 aptamer and Alexa Fluor 488 aptamer |
1.797 ng/mL and 1.484 ng/mL |
[53] |
Other nanomaterials
|
Silica nanoparticles |
Thiram |
Mesoporous silica with gold nanoparticles |
0.19 ng/mL |
[15] |
Silica nanoparticles |
Aflatoxin B1
|
DNA aptamer |
0.13 ng/mL |
[54] |
Up-conversion nanoparticles |
Staphylococcus aureus |
Aptamer-functionalized gold nanoparticles |
10.7 CFU/mL |
[55] |
Up-conversion nanoparticles |
Histamine |
Up-conversion nanoparticles |
7.34 mg/L |
[56] |
Metal organic frameworks (MOF) |
Acrylamide |
6-carboxyfluorescein-labeled aptamer (FAM-ssDNA) |
1.9 nM |
[57] |
Metal organic frameworks |
Tetracycline antibiotics |
Luminescent MOF |
0.28–0.30 μM |
[58] |
Metal organic frameworks |
Ethanolamine |
Zeolitic imidazolate framework-8/FAM-aptamer |
17.86 pM |
[59] |
Phosphors |
Zearalenone in cereals |
Black phosphorus–gold nanocomposite |
2 μg/kg |
[60] |